Posology and Serum-/Xeno-Free Engineered Adipose Stromal Cells Cell Sheets
- PMID: 35557946
- PMCID: PMC9086846
- DOI: 10.3389/fcell.2022.873603
Posology and Serum-/Xeno-Free Engineered Adipose Stromal Cells Cell Sheets
Abstract
Well-characterized adipose stem cells and chemically defined culture media are important factors that control the production of the cell sheet, used in translational medicine. In this study, we have developed and engineered multilayer adipose stem cell cell sheets (ASCCSs) using chemically defined/serum-free culture media: undifferentiated or differentiated into osteoblasts and chondrocytes. In addition, using the cell sheet transmittance, we estimated the number of cells per cell sheet. Undifferentiated ASCCSs were engineered in 10 days, using serum-free/xeno-free culture media. They were CD29+, CD73+, CD90+, CD105+, HLA-A+, and HLA-DR-. ASCCSs differentiated into chondrocytes and osteoblasts were also engineered using chemically defined and animal-free culture media, in only 14 days. The addition of an ROCK inhibitor improved the chondrocyte cell sheet engineering. The decrease in the cell sheet transmittance rate was higher for the osteoblast cell sheets due to the intracellular Ca2+ accumulation. The estimation of cell number per cell sheet was carried out with the transmittance, which will provide important information for cell sheet posology. In conclusion, three types of ASCCSs were engineered using serum-free, xeno-free culture media, expressing their specific markers. Their transmittance measurement allowed estimating the number of cells per cell sheet, with a non-invasive methodology.
Keywords: cell sheets; mesenchymal stem cells; multilayer; posology; serum-/xeno free; transmittance.
Copyright © 2022 Ochiai, Villanueva, Niihara, Niihara and Oliva.
Conflict of interest statement
Authors LV, YN, and JOl are employed by Emmaus Life Sciences, Inc. and HN, JOc were employed by Emmaus Life Sciences, Inc. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Measurement of the Adipose Stem Cells Cell Sheets Transmittance.Bioengineering (Basel). 2021 Jul 2;8(7):93. doi: 10.3390/bioengineering8070093. Bioengineering (Basel). 2021. PMID: 34356200 Free PMC article.
-
Engineering, differentiation and harvesting of human adipose-derived stem cell multilayer cell sheets.Regen Med. 2019 Mar;14(3):151-163. doi: 10.2217/rme-2018-0053. Epub 2019 Mar 4. Regen Med. 2019. PMID: 30829557
-
Xeno-free and shrinkage-free preparation of scaffold-free cartilage-like disc-shaped cell sheet using human bone marrow mesenchymal stem cells.J Biosci Bioeng. 2013 Dec;116(6):734-9. doi: 10.1016/j.jbiosc.2013.05.019. Epub 2013 Jul 10. J Biosci Bioeng. 2013. PMID: 23849744
-
Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media.Biotechnol J. 2013 Apr;8(4):448-58. doi: 10.1002/biot.201200340. Epub 2013 Mar 7. Biotechnol J. 2013. PMID: 23420807
-
Influences of Xeno-Free Media on Mesenchymal Stem Cell Expansion for Clinical Application.Tissue Eng Regen Med. 2021 Feb;18(1):15-23. doi: 10.1007/s13770-020-00306-z. Epub 2020 Nov 4. Tissue Eng Regen Med. 2021. PMID: 33150562 Free PMC article. Review.
Cited by
-
Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration.Int J Mol Sci. 2024 Jun 20;25(12):6805. doi: 10.3390/ijms25126805. Int J Mol Sci. 2024. PMID: 38928517 Free PMC article. Review.
References
-
- Administration FDA(2020a). Bovine Derived Materials Used in Vaccine Manufacturing Questions and Answers. Available at: https://www.fda.gov/vaccines-blood-biologics/questions-about-vaccines/bo....
-
- Administration FDA(2020b). Cellular & Gene Therapy Guidances. Available at: https://www.fda.gov/vaccines-blood-biologics/biologics-guidances/cellula....
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous